Which Genetics Variants in DNase-Seq Footprints Are More Likely to Alter Binding?

Large experimental efforts are characterizing the regulatory genome, yet we are still missing a systematic definition of functional and silent genetic variants in non-coding regions. Here, we integrated DNaseI footprinting data with sequence-based transcription factor (TF) motif models to predict th...

Full description

Bibliographic Details
Main Authors: Gregory A Moyerbrailean, Cynthia A Kalita, Chris T Harvey, Xiaoquan Wen, Francesca Luca, Roger Pique-Regi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-02-01
Series:PLoS Genetics
Online Access:http://europepmc.org/articles/PMC4764260?pdf=render
id doaj-3f26b1e8dbfb43d88585cf94cd32c647
record_format Article
spelling doaj-3f26b1e8dbfb43d88585cf94cd32c6472020-11-25T00:07:26ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042016-02-01122e100587510.1371/journal.pgen.1005875Which Genetics Variants in DNase-Seq Footprints Are More Likely to Alter Binding?Gregory A MoyerbraileanCynthia A KalitaChris T HarveyXiaoquan WenFrancesca LucaRoger Pique-RegiLarge experimental efforts are characterizing the regulatory genome, yet we are still missing a systematic definition of functional and silent genetic variants in non-coding regions. Here, we integrated DNaseI footprinting data with sequence-based transcription factor (TF) motif models to predict the impact of a genetic variant on TF binding across 153 tissues and 1,372 TF motifs. Each annotation we derived is specific for a cell-type condition or assay and is locally motif-driven. We found 5.8 million genetic variants in footprints, 66% of which are predicted by our model to affect TF binding. Comprehensive examination using allele-specific hypersensitivity (ASH) reveals that only the latter group consistently shows evidence for ASH (3,217 SNPs at 20% FDR), suggesting that most (97%) genetic variants in footprinted regulatory regions are indeed silent. Combining this information with GWAS data reveals that our annotation helps in computationally fine-mapping 86 SNPs in GWAS hit regions with at least a 2-fold increase in the posterior odds of picking the causal SNP. The rich meta information provided by the tissue-specificity and the identity of the putative TF binding site being affected also helps in identifying the underlying mechanism supporting the association. As an example, the enrichment for LDL level-associated SNPs is 9.1-fold higher among SNPs predicted to affect HNF4 binding sites than in a background model already including tissue-specific annotation.http://europepmc.org/articles/PMC4764260?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Gregory A Moyerbrailean
Cynthia A Kalita
Chris T Harvey
Xiaoquan Wen
Francesca Luca
Roger Pique-Regi
spellingShingle Gregory A Moyerbrailean
Cynthia A Kalita
Chris T Harvey
Xiaoquan Wen
Francesca Luca
Roger Pique-Regi
Which Genetics Variants in DNase-Seq Footprints Are More Likely to Alter Binding?
PLoS Genetics
author_facet Gregory A Moyerbrailean
Cynthia A Kalita
Chris T Harvey
Xiaoquan Wen
Francesca Luca
Roger Pique-Regi
author_sort Gregory A Moyerbrailean
title Which Genetics Variants in DNase-Seq Footprints Are More Likely to Alter Binding?
title_short Which Genetics Variants in DNase-Seq Footprints Are More Likely to Alter Binding?
title_full Which Genetics Variants in DNase-Seq Footprints Are More Likely to Alter Binding?
title_fullStr Which Genetics Variants in DNase-Seq Footprints Are More Likely to Alter Binding?
title_full_unstemmed Which Genetics Variants in DNase-Seq Footprints Are More Likely to Alter Binding?
title_sort which genetics variants in dnase-seq footprints are more likely to alter binding?
publisher Public Library of Science (PLoS)
series PLoS Genetics
issn 1553-7390
1553-7404
publishDate 2016-02-01
description Large experimental efforts are characterizing the regulatory genome, yet we are still missing a systematic definition of functional and silent genetic variants in non-coding regions. Here, we integrated DNaseI footprinting data with sequence-based transcription factor (TF) motif models to predict the impact of a genetic variant on TF binding across 153 tissues and 1,372 TF motifs. Each annotation we derived is specific for a cell-type condition or assay and is locally motif-driven. We found 5.8 million genetic variants in footprints, 66% of which are predicted by our model to affect TF binding. Comprehensive examination using allele-specific hypersensitivity (ASH) reveals that only the latter group consistently shows evidence for ASH (3,217 SNPs at 20% FDR), suggesting that most (97%) genetic variants in footprinted regulatory regions are indeed silent. Combining this information with GWAS data reveals that our annotation helps in computationally fine-mapping 86 SNPs in GWAS hit regions with at least a 2-fold increase in the posterior odds of picking the causal SNP. The rich meta information provided by the tissue-specificity and the identity of the putative TF binding site being affected also helps in identifying the underlying mechanism supporting the association. As an example, the enrichment for LDL level-associated SNPs is 9.1-fold higher among SNPs predicted to affect HNF4 binding sites than in a background model already including tissue-specific annotation.
url http://europepmc.org/articles/PMC4764260?pdf=render
work_keys_str_mv AT gregoryamoyerbrailean whichgeneticsvariantsindnaseseqfootprintsaremorelikelytoalterbinding
AT cynthiaakalita whichgeneticsvariantsindnaseseqfootprintsaremorelikelytoalterbinding
AT christharvey whichgeneticsvariantsindnaseseqfootprintsaremorelikelytoalterbinding
AT xiaoquanwen whichgeneticsvariantsindnaseseqfootprintsaremorelikelytoalterbinding
AT francescaluca whichgeneticsvariantsindnaseseqfootprintsaremorelikelytoalterbinding
AT rogerpiqueregi whichgeneticsvariantsindnaseseqfootprintsaremorelikelytoalterbinding
_version_ 1725418219559190528